Related subjects
Introduction
This week’s roundup brings together five Evirena research articles: a human Centella trial after wisdom-tooth surgery, an in-vitro herbal-tea/drug interaction study, metabolomic testing of coriander/celery/parsley against resistant E. coli, a critical review of ginger’s antimicrobial evidence, and a field trial on summer-savory fertilization and essential oil. Each item includes study date, location and a link to the full analysis.
On this page
Weekly roundup
This digest covers research reviewed by Evirena during 16–23 October 2026. Each study has its own full article; this page is a weekly index, not a substitute for the detailed analysis.
1. Centella mouthwash after wisdom-tooth surgery
Evirena article published: 2026-10-23
Original study: 21 October 2026.
Location: Oral and Maxillofacial Surgery, Faculty of Dentistry, Chiang Mai University, Thailand.
Design: randomized double-blind placebo-controlled trial, 36 participants.
A 0.12% Centella asiatica leaf-extract mouthwash did not significantly improve wound healing (p=0.105), pain or swelling. Human evidence is more directly relevant than laboratory work, but this trial was small and followed participants for seven days. [1]
Full Evirena article: Read the full article
2. Sela tea with blood-pressure and diabetes medicines
Evirena article published: 2026-10-23
Original study: 22 October 2026.
Location: AMITD, Department of Pharmacology, University of the Free State, Bloemfontein, South Africa.
Design: in-vitro study.
Two commercial Sela products were combined with lisinopril, aliskiren and acarbose. Some enzyme inhibition became stronger, but patients, blood pressure, glucose and pharmacokinetics were not studied. It is an interaction signal to investigate, not proof of clinical benefit or harm. [2]
Full Evirena article: Read the full article
3. Coriander, celery and parsley against resistant uropathogenic E. coli
Evirena article published: 2026-10-23
Original study: 21 October 2026.
Location: Egyptian institutions in Cairo/Alexandria with University of Porto, Portugal; isolates from diagnostic laboratories in Alexandria.
Design: metabolomics and in-vitro bacterial assays.
Researchers profiled 167 metabolites and tested extracts against 20 multidrug-resistant UPEC isolates. Coriander was the strongest laboratory extract (MIC 3.75 µg/mL), but solvent extracts tested outside the body do not show that eating the herbs treats UTI. [3]
Full Evirena article: Read the full article
4. Ginger as an antimicrobial: critical review
Evirena article published: 2026-10-23
Original paper: 21 October 2026.
Institutions: researchers in Malaysia, Australia and Taiwan; no single experiment site.
Type: peer-reviewed critical narrative review, not a clinical trial or meta-analysis.
The review found repeated laboratory antimicrobial signals but emphasized inconsistent preparations, limited standardization, metabolism of gingerols/shogaols and few controlled clinical trials. Laboratory activity is not proven infection treatment. [4]
Full Evirena article: Read the full article
5. Summer-savory fertilization and essential-oil percentage
Evirena article published: 2026-10-23
Original study: 17 October 2026.
Country/institutions: Iran; University of Mohaghegh Ardabili and Shahid Beheshti University.
Design: single-location, single-season agronomic field trial.
Three Satureja hortensis ecotypes were compared under five fertilizer regimes. High organic manure favoured Shiraz biomass, while high NPK was associated with some reproductive traits and higher essential-oil percentage. This is an agricultural finding; more oil does not establish greater therapeutic value. [5]
Full Evirena article: Read the full article
What this week teaches us
These five papers sit at different evidence levels: a small human trial, two laboratory studies, a critical review and an agricultural experiment. “Peer reviewed” does not make them equally capable of proving a human health effect.
The recurring editorial rule is to distinguish food from concentrated extracts, laboratory outcomes from clinical outcomes, and plant composition from therapeutic effectiveness.
Conclusion
This week did not produce a reason to replace established medicines with herbs or oils. It produced useful research questions: can the Centella signal be tested in larger trials, do tea–drug enzyme interactions occur in people, which Apiaceae compounds merit development, and how can ginger and savory materials be standardized before clinical claims are made?
Important note
The weekly roundup is a summary and does not replace the full Evirena article or original paper. Laboratory and agricultural studies do not establish therapeutic effectiveness in humans. Do not change medicines or doses on the basis of these studies without appropriate clinical evidence.
This article provides educational information and does not replace advice from a qualified healthcare professional.
Sources and references
- Effect of Centella asiatica extract mouthwash on oral wound healing following mandibular third molar surgery: Randomized controlled trial · Read source — BMC Complementary Medicine and Therapies
- Evaluating the efficacy of commercial Sela tea-high blood and Sela tea-blood sugar in combination with antihypertensive and anti-diabetic drugs: an in vitro study · Read source — Clinical Phytoscience
- Integrative metabolomics and chemometric analysis reveal metabolites associated with antibacterial and antibiofilm activities of celery, Coriander, and parsley against multidrug-resistant uropathogenic Escherichia coli · Read source — BMC Complementary Medicine and Therapies
- From cultivation to clinical translation: a critical review of ginger phytochemistry, antimicrobial mechanisms, bioavailability, and standardization · Read source — Beni-Suef University Journal of Basic and Applied Sciences
- Multi-dimensional analysis of fertilizer-treated Satureja hortensis L. ecotypes: growth dynamics, biomass production, and phytochemical fingerprints · Read source — BMC Plant Biology